Citrate inhibits growth of residual fragments in an in vitro model of calcium oxalate renal stones

Kidney International

Volumn 65, Issue 5, 2004, Pages 1724-1730

  Chow, Karyee ^a   Dixon, James ^a   Gilpin, Sally ^a   Kavanagh, John P ^a   Rao, Popduri N ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Calcium oxalate; Citrate; Nephrolithiasis

Indexed keywords

CALCIUM OXALATE; CITRIC ACID;

CONFERENCE PAPER; CRYSTALLIZATION; HUMAN; IONIZATION; MACROMOLECULE; NEPHROLITHIASIS; PH MEASUREMENT; PRIORITY JOURNAL; URINE;

EID: 2342618182     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00566.x     Document Type: Conference Paper

References (33)

1. TISELIUS H-G: Epidemiology and medical management of stone disease. Br J Urol Int 91:758-767, 2003
2. NEWMAN DM, SCOTT JW: Long term follow-up of 2617 extracorporeal shock wave lithotripsy patients. J Urol 137:141A, 1987
3. DRACH GW, DRETLER S, FAIR W, et al: Report of the United States Cooperative Study of Extracorporeal Shock Wave Lithotripsy. J Urol 135:1127-1133, 1986
4. RIEHLE RA, FAIR WR, VAUGHAN ED: Extracorporeal shock-wave lithotripsy for upper urinary tract calculi: One year's experience at a single center. JAMA 255:2043-2048, 1986
5. LINGEMAN JE, NEWMAN D, MERTZ JHO, et al. Extracoporeal shock wave lithotripsy: The Methodist Hospital of Indiana experience. J Urol 135:1134-1137, 1986
6. FINE JK, PAK CY, PREMINGER GM: Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy. J Urol 153:27-32, 1995
7. PAK CYC: Citrate and renal calculi; new insights and future directions. Am J Kidney Dis 17:420-425, 1991
8. CICERELLO E, MERLO F, GAMBARO G, et al: Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients. J Urol 151:5-9, 1994
9. SOYGUR T, AKBAY A, KUPELI S: Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: A randomized controlled trial. J Endourol 16:149-152, 2002
10. OEHLSCHLÄGER S, ALBRECHT S, HAKENBERG OW, et al: Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsy. Urology 62:17-21, 2003
11. HESS B, RYALL RL, KAVANAGH JP, et al: Method for measuring crystallization in urolithiasis research: why, how and when? Eur Urol 40:220-230, 2001
12. ANANTH K, KAVANAGH JP, WALTON RC, RAO PN: Enlargement of calcium oxalate stones to clinically significantly size in an in-vitro stone generator. Br J Urol Int 90:939-944, 2002
13. CHOW K, DIXON J, GILPIN S, et al: A stone farm: development of a method for simultaneous production of multiple calcium oxalate stones in vitro. Urol Res 32:55-60, 2004
14. TISELIUS H-G, BERG C, FORNANDER A-M, NILSSON M-A: Effects of citrate on the different phases of calcium oxalate crystallization. Scann Microsc 7:381-390, 1993
15. PAK CYC, FULLER C, SAKHAEE K, et al: Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol 134:11-19, 1985
16. PREMINGER GM, SAKHAEE K, SKURLA C, PAK CYC: Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol 134:20-23, 1985
17. BARCELO P, WUHL O, SERVITGE E, et al: Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150:1761-1764, 1993
18. WHALLEY NA, MEYERS AM, MARTINS M, MARGOLIUS LP: Long term effects of potassium citrate therapy on the formation of new stones in groups of recurrent stone formers with hypocitraturia. Br J Urol 78:10-14, 1996
19. ETTINGER B, PAK CYC, CITRON JT, et al: Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158:2069-2073, 1997
20. HESSE A, CLASSEN A, KNOLL M, et al: Dependence of urine composition on the age and sex of healthy subjects. Clin Chim Acta 160:79-86, 1986
21. CURHAN GC, WILLETT WC, SPEIZER FE, STAMPFER MJ: Twenty-four-hour urine chemistries and the risk of kidney stones among men and women. Kidney Int 59:2290-2298, 2001
22. PEARLE MS, ROEHRBORN CG, PAK CY: Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 13:679-685, 1999
23. ESEN T, MARSHALL VR, RAO PN, et al: Medical management of urolithiasis, in Proceedings of 1st International Consultation On Stone Disease, edited by Segura J, Conort P, Khoury S, et al: Editions 21, France, 2003, pp 133-149
24. SUZUKI K, TSUGAWA R, RYALL RL: Inhibition by Sodium-potassium citrate (CG-120) of calcium oxalate crystal growth on to kidney stone fragments obtained from extracorporeal shock wave lithotripsy. Br J Urol 68:132-137, 1991
25. YASUI T, SATO M, FUJITA K, TOZAWA K, et al: Effects of citrate on renal stone formation and osteopontin expression in a rat urolithiasis model. Urol Res 29:50-56, 2001
26. GILL WB, KARESH W, GARSIN L, ROMA MJ: Inhibitory effects of urinary macromolecules on the crystallization of calcium oxalate. Inv Urol 15:95-99, 1977
27. DRACH GW, KRALJEVICH Z, RANDOLPH AD: Effects of high molecular weight urinary macromolecules on crystallization of calcium oxalate dihydrate. J Urol 127:805-810, 1982
28. EDYVANE K, HIBBERD CM, HARNETT RM, et al: Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole human urine. Clin Chim Acta 167:329-338, 1987
29. HESS B, NAKAGAWA Y, COE FL: Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 257:F99-F106, 1989
30. HESS B: The role of Tamm-Horsfall glycoprotein and nephrocalcin in calcium oxalate monohydrate crystallization processes. Scann Microsc 5:689-695, 1991
31. HESS B: Tamm-Horsfall glycoprotein - Inhibitor or promoter of calcium oxalate monohydrate crystallization processes? Urol Res 20:83-86, 1992
32. EBISUNO S, KOHJIMOTO Y, YOSHIDA T, OHKAWA T: Effect of urinary macromolecules on aggregation of calcium oxalate in recurrent calcium stone formers and healthy. Urol Res 21:265-268, 1993
33. RODGERS AL, BALL D, HARPER W: Effect of urinary macromolecules and chondroitin sulphate on calcium oxalate crystallization in urine. Scann Microsc 8:71-77, 1994